Listen to experienced IP professionals discuss how best to right size your IP spending to strike the right balance between reducing IP costs and building your company’s IP position and technology value. This panel discusses how the changing IP regulatory environment may impact these decisions.
Moderator: John T. Gutkoski
Panelists:
David Cerveny, Vice President Intellectual Property and General Counsel, ConforMIS, Inc.
Wendy Rieder, General Counsel and Vice President Intellectual Property and Legal Affairs, Synta Pharmaceuticals Corp.
Steve Tannenbaum, Executive Vice President and Chief Financial Officer, Collegium Pharmaceutical, Inc.
Related Insights
19 February 2025
Foley Viewpoints
FinCEN Resumes Corporate Transparency Act Enforcement
The last remaining nationwide injunction prohibiting enforcement of the Corporate Transparency Act (CTA) has been stayed, clearing the way for the federal government to resume enforcing the CTA.
27 February 2025
Events
Coping with Tariff Uncertainty: Managing International Trade Risks Under the Trump Administration
The Trump Administration has issued multiple announcements that it will be sharply raising tariffs on most of the major U.S. trading partners, including 10 percent tariffs on China, 25 percent tariffs on Canada and Mexico (suspended for 30 days), and 25 percent tariffs on all imports of aluminum and steel products.
19 February 2025
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.